Home monitoring with technology-supported management in chronic heart failure: a randomised trial

OBJECTIVES:<br>We aimed to investigate whether digital home monitoring with centralised specialist support for remote management of heart failure (HF) is more effective in improving medical therapy and patients' quality of life than digital home monitoring alone. <br><br>METHO...

Full description

Bibliographic Details
Main Authors: Rahimi, K, Nazarzadeh, M, Pinho-Gomes, A-C, Woodward, M, Salimi-Khorshidi, G, Ohkuma, T, Fitzpatrick, R, Tarassenko, L, Denis, M, Cleland, J
Other Authors: SUPPORT-HF2 Study Group
Format: Journal article
Language:English
Published: BMJ Publishing Group 2020
_version_ 1797110515958284288
author Rahimi, K
Nazarzadeh, M
Pinho-Gomes, A-C
Woodward, M
Salimi-Khorshidi, G
Ohkuma, T
Fitzpatrick, R
Tarassenko, L
Denis, M
Cleland, J
author2 SUPPORT-HF2 Study Group
author_facet SUPPORT-HF2 Study Group
Rahimi, K
Nazarzadeh, M
Pinho-Gomes, A-C
Woodward, M
Salimi-Khorshidi, G
Ohkuma, T
Fitzpatrick, R
Tarassenko, L
Denis, M
Cleland, J
author_sort Rahimi, K
collection OXFORD
description OBJECTIVES:<br>We aimed to investigate whether digital home monitoring with centralised specialist support for remote management of heart failure (HF) is more effective in improving medical therapy and patients' quality of life than digital home monitoring alone. <br><br>METHODS:<br>In a two-armed partially blinded parallel randomised controlled trial, seven sites in the UK recruited a total of 202 high-risk patients with HF (71.3 years SD 11.1; left ventricular ejection fraction 32.9% SD 15.4). Participants in both study arms were given a tablet computer, Bluetooth-enabled blood pressure monitor and weighing scales for health monitoring. Participants randomised to intervention received additional regular feedback to support self-management and their primary care doctors received instructions on blood investigations and pharmacological treatment. The primary outcome was the use of guideline-recommended medical therapy for chronic HF and major comorbidities, measured as a composite opportunity score (total number of recommended treatment given divided by the total number of opportunities the treatment should have been given, with a score 1 indicating 100% adherence to recommendations). Co-primary outcome was change in physical score of Minnesota Living with Heart Failure questionnaire.<br><br> RESULTS:<br>101 patients were randomised to 'enhanced self-management' and 101 to 'supported medical management'. At the end of follow-up, the opportunity score was 0.54 (95% CI 0.46 to 0.62) in the control arm and 0.61 (95% CI 0.52 to 0.70) in the intervention arm (p=0.25). Physical well-being of participants also did not differ significantly between the groups (17.4 (12.4) mean (SD) for control arm vs 16.5 (12.1) in treatment arm; p for change=0.84). <br><br>CONCLUSIONS:<br>Central provision of tailored specialist management in a multi-morbid HF population was feasible. However, there was no strong evidence for improvement in use of evidence-based treatment nor health-related quality of life.<br><br> Trial registration number ISRCTN86212709
first_indexed 2024-03-07T07:57:26Z
format Journal article
id oxford-uuid:5df69de8-5fad-41cc-8629-9653e63311d1
institution University of Oxford
language English
last_indexed 2024-03-07T07:57:26Z
publishDate 2020
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:5df69de8-5fad-41cc-8629-9653e63311d12023-08-24T13:40:06ZHome monitoring with technology-supported management in chronic heart failure: a randomised trialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5df69de8-5fad-41cc-8629-9653e63311d1EnglishSymplectic ElementsBMJ Publishing Group2020Rahimi, KNazarzadeh, MPinho-Gomes, A-CWoodward, MSalimi-Khorshidi, GOhkuma, TFitzpatrick, RTarassenko, LDenis, MCleland, JSUPPORT-HF2 Study GroupOBJECTIVES:<br>We aimed to investigate whether digital home monitoring with centralised specialist support for remote management of heart failure (HF) is more effective in improving medical therapy and patients' quality of life than digital home monitoring alone. <br><br>METHODS:<br>In a two-armed partially blinded parallel randomised controlled trial, seven sites in the UK recruited a total of 202 high-risk patients with HF (71.3 years SD 11.1; left ventricular ejection fraction 32.9% SD 15.4). Participants in both study arms were given a tablet computer, Bluetooth-enabled blood pressure monitor and weighing scales for health monitoring. Participants randomised to intervention received additional regular feedback to support self-management and their primary care doctors received instructions on blood investigations and pharmacological treatment. The primary outcome was the use of guideline-recommended medical therapy for chronic HF and major comorbidities, measured as a composite opportunity score (total number of recommended treatment given divided by the total number of opportunities the treatment should have been given, with a score 1 indicating 100% adherence to recommendations). Co-primary outcome was change in physical score of Minnesota Living with Heart Failure questionnaire.<br><br> RESULTS:<br>101 patients were randomised to 'enhanced self-management' and 101 to 'supported medical management'. At the end of follow-up, the opportunity score was 0.54 (95% CI 0.46 to 0.62) in the control arm and 0.61 (95% CI 0.52 to 0.70) in the intervention arm (p=0.25). Physical well-being of participants also did not differ significantly between the groups (17.4 (12.4) mean (SD) for control arm vs 16.5 (12.1) in treatment arm; p for change=0.84). <br><br>CONCLUSIONS:<br>Central provision of tailored specialist management in a multi-morbid HF population was feasible. However, there was no strong evidence for improvement in use of evidence-based treatment nor health-related quality of life.<br><br> Trial registration number ISRCTN86212709
spellingShingle Rahimi, K
Nazarzadeh, M
Pinho-Gomes, A-C
Woodward, M
Salimi-Khorshidi, G
Ohkuma, T
Fitzpatrick, R
Tarassenko, L
Denis, M
Cleland, J
Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title_full Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title_fullStr Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title_full_unstemmed Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title_short Home monitoring with technology-supported management in chronic heart failure: a randomised trial
title_sort home monitoring with technology supported management in chronic heart failure a randomised trial
work_keys_str_mv AT rahimik homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT nazarzadehm homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT pinhogomesac homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT woodwardm homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT salimikhorshidig homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT ohkumat homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT fitzpatrickr homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT tarassenkol homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT denism homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial
AT clelandj homemonitoringwithtechnologysupportedmanagementinchronicheartfailurearandomisedtrial